Biotech in the Belt-Tightening Era: The Photos

Biotech in the Belt-Tightening Era: The Photos
Genomic Health CEO Kim Popovits (left) made the trip from the Bay Area to join the speaker lineup, and connect with friends and colleagues in the Seattle biotech industry. Genomic Health's VP of communications, Emily Faucette (center) joined her.
Read more on Xconomy

Wall Street Backs the Wrong Biotech
In this video, David Williamson reviews some of his favorite biotech firms. Many analysts have thrown their weight behind Biogene (NASDAQ: BIIB ) and its new BG12 drug for multiple sclerosis. However, David favors Gilead (NASDAQ: GILD ) over Biogene …
Read more on Motley Fool

3 Speculative Biotech Stocks to Buy Now
Health care analyst Max Macaluso recently sat down with Fool contributor Keith Speights to talk about some of the best speculative biotech plays on the market. Max and Keith discussed three companies that investors should consider: Keryx …
Read more on Motley Fool

Leave a Reply